Cargando…
Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptotic protein and is considered as a tumor suppressor. Loss of WWOX ge...
Autores principales: | Chiang, Ming-Fu, Chou, Pei-Yi, Wang, Wan-Jen, Sze, Chun-I, Chang, Nan-Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586680/ https://www.ncbi.nlm.nih.gov/pubmed/23459853 http://dx.doi.org/10.3389/fonc.2013.00043 |
Ejemplares similares
-
A p53/TIAF1/WWOX triad exerts cancer suppression but may cause brain protein aggregation due to p53/WWOX functional antagonism
por: Chou, Pei-Yi, et al.
Publicado: (2019) -
WWOX Phosphorylation, Signaling, and Role in Neurodegeneration
por: Liu, Chan-Chuan, et al.
Publicado: (2018) -
Assessing Current Therapeutic Approaches to Decode Potential Resistance Mechanisms in Glioblastomas
por: Sze, Chun-I, et al.
Publicado: (2013) -
HYAL-2–WWOX–SMAD4 Signaling in Cell Death and Anticancer Response
por: Hsu, Li-Jin, et al.
Publicado: (2016) -
WWOX Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions
por: Pospiech, Karolina, et al.
Publicado: (2018)